273 related articles for article (PubMed ID: 37772692)
1. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY
J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692
[No Abstract] [Full Text] [Related]
2. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
Ford AC; Harris LA; Lacy BE; Quigley EMM; Moayyedi P
Aliment Pharmacol Ther; 2018 Nov; 48(10):1044-1060. PubMed ID: 30294792
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
Asha MZ; Khalil SFH
Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
[TBL] [Abstract][Full Text] [Related]
5. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
Ooi SL; Correa D; Pak SC
Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
7. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y
BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
Didari T; Mozaffari S; Nikfar S; Abdollahi M
World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
[TBL] [Abstract][Full Text] [Related]
9. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
Simon E; Călinoiu LF; Mitrea L; Vodnar DC
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
11. Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?
di Michele F
Curr Med Chem; 2022; 29(12):2075-2092. PubMed ID: 34533437
[TBL] [Abstract][Full Text] [Related]
12. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews.
Whelan K
Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):581-7. PubMed ID: 21892075
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
Sun JR; Kong CF; Qu XK; Deng C; Lou YN; Jia LQ
Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Zhang T; Zhang C; Zhang J; Sun F; Duan L
Front Cell Infect Microbiol; 2022; 12():859967. PubMed ID: 35433498
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
[TBL] [Abstract][Full Text] [Related]
16. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
17. Review article: probiotics and prebiotics in irritable bowel syndrome.
Spiller R
Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials.
Niu HL; Xiao JY
Int J Surg; 2020 Mar; 75():116-127. PubMed ID: 32014597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
